A Study of LY3209590 in Participants With Type 2 Diabetes Mellitus

NCT03736785 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

399

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: LY3209590
DRUG: Insulin Degludec

Sponsor

Eli Lilly and Company